Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) recently released the poll results of its adjourned H Shareholders’ Class Meeting, held on 3 December 2025. The total number of issued H Shares entitled to vote was 95,140,500, and shareholders holding 21,965,737 shares attended or were represented. All proposed special resolutions required a two-thirds majority but did not achieve that threshold.

Three motions were tabled: the abolishment of the Supervisory Committee and corresponding amendments to the Articles of Association; amendments to the Rules of Procedures of the General Meetings; and amendments to the Rules of Procedures of the Board Meetings. The voting results showed that each resolution garnered less than the necessary two-thirds approval. As a result, the Supervisory Committee remains in place, and the existing Articles of Association and the Rules of Procedures remain effective.

All directors of the company participated in the meeting either in person or by telephone. Independent legal advisers concluded that the meeting adhered to applicable regulations and that the voting procedures and results were valid. Beijing Chunlizhengda Medical Instruments Co., Ltd. will continue to comply with current regulations, Articles of Association, and relevant procedures following these results.